Core Viewpoint - The company, 科劲国际 (06822.HK), anticipates a loss of approximately HKD 40 million for the six months ending June 30, 2025, a significant decline from a profit of about HKD 3.4 million in the previous period [1] Financial Performance - The primary reason for the shift from profit to loss is a substantial increase in administrative expenses due to depreciation and other operational costs associated with the commencement of nanofiber production at the advanced manufacturing center in Tseung Kwan O [1] - Other income and gains have drastically decreased from a profit of approximately HKD 3.7 million in the previous period to a loss of about HKD 6.8 million [1] - Revenue has fallen from approximately HKD 334 million in the previous period to about HKD 250 million [1]

Core Viewpoint - The company, 科劲国际 (06822), anticipates a loss of approximately 40 million HKD for the six months ending June 30, 2025, a significant decline from a profit of about 3.4 million HKD in the same period last year [1] Financial Performance - The primary reason for the shift from profit to loss is a substantial increase in administrative expenses due to the depreciation and other operational costs associated with the commencement of nanofiber production at the advanced manufacturing center in Tseung Kwan O [1] - Other income and gains/losses have drastically decreased from a profit of approximately 3.7 million HKD in the previous period to a loss of about 6.8 million HKD, primarily due to adverse conditions in the commercial real estate market, leading to a fair value loss on investment properties that rose from about 4 million HKD to approximately 16.9 million HKD [1] - Revenue has decreased from approximately 334 million HKD in the previous period to about 250 million HKD, mainly due to uncertainties surrounding U.S. tariffs and expanded policy outlooks [1]

Core Viewpoint - The company, 科劲国际 (06822.HK), expects to report a loss of approximately 40 million HKD for the six months ending June 30, 2025, compared to a profit of about 3.4 million HKD in the same period last year [1] Group 1: Financial Performance - The shift from profit to loss is primarily attributed to a significant increase in administrative expenses due to the depreciation and operational costs associated with the advanced manufacturing center in Tseung Kwan O, which has commenced nano-fiber production [1] - Other income and gains/losses have drastically decreased from a profit of approximately 3.7 million HKD in the previous period to a loss of about 6.8 million HKD, largely due to fair value losses on investment properties, which rose from about 4 million HKD to approximately 16.9 million HKD [1] - Revenue has decreased from approximately 334 million HKD in the previous period to about 250 million HKD in the current reporting period, primarily due to uncertainties surrounding U.S. tariffs and expanded policy outlooks [1]

Core Viewpoint - The company, 科劲国际 (06822), anticipates a loss of approximately 40 million HKD for the six months ending June 30, 2025, a significant decline from a profit of about 3.4 million HKD in the same period last year [1] Financial Performance - The primary reason for the shift from profit to loss is a substantial increase in administrative expenses due to the depreciation and other operational costs associated with the commencement of nanofiber production at the advanced manufacturing center in Tseung Kwan O [1] - Other income and gains/losses have drastically decreased from a profit of approximately 3.7 million HKD in the previous period to a loss of about 6.8 million HKD, primarily due to fair value losses on investment properties, which rose from approximately 4 million HKD to about 16.9 million HKD [1] - Revenue has decreased from approximately 334 million HKD in the previous period to about 250 million HKD, mainly due to uncertainties surrounding U.S. tariffs and expanded policy outlooks [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 佈 全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 本公司董事會（「董事會」）謹 此 知 會 本 公 司 股 東 及 有 意 投 資 者，根 據 現 有 可 得 資 料及董事會對本集團截至二零二五年六月三十日止六個月（「報告期」）未經審 核 綜 合 管 理 賬 目 的 初 步 審 閱，本 集 團 預 期 於 報 告 期 錄 得 虧 損 約4千 萬 港 元，而 去年同期（「上一期間」）則錄得溢利約3.4百 萬 港 元。 表 現 由 盈 轉 虧 的 主 要 原 因 為： – 1 – (i) 行政開支因本集團位於將軍澳工業邨的先進製造業中心開始投入納米纖 維 生 產 運 營 後 於 報 告 期 產 生 折 舊 及 其 他 運 營 成 本 而 大 幅 上 升； (ii) 其他收入以及收益及虧損由上一期間收益約3.7百萬港元大幅下降至虧損 約6.8百 萬 港 元，主 要 由 於 受 工 商 業 房 地 產 市 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年7月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 科勁國際（控股）有限公司（於開曼群島註冊成立的有限公司） 呈交日期: 2025年8月1日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 06822 | 說明 | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | 法定/註冊股本 | | | 上月底結存 | | | 10,000,000,000 | HKD | | 0.01 HKD | | 100,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | 本月底結存 | | | 10,000,000,000 | HKD | | 0.01 HKD | | 100,000,000 | 本月底法定/ ...

格隆汇7月30日丨科劲国际(06822.HK)宣布，董事会会议将于2025年8月22日(星期五)在公司总部及香港 主要营业地点香港干诺道西3号亿利商业大厦12楼举行，藉以(其中包括)批准公司及其附属公司截至 2025年6月30日止六个月的未经审核综合中期业绩及其刊发，以及考虑宣派中期股息(如有)的推荐建 议。 ...

（於開曼群島註冊成立的有限公司） （股份代號：6822） 董事會會議通告 香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 佈 全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 King's Flair International (Holdings) Limited 科勁國際（控 股）有限公司 承董事會命 科勁國際（控 股）有限公司 主席兼執行董事 黃少華博士 香 港，二 零 二 五 年 七 月 三 十 日 於 本 公 佈 日 期，董 事 會 包 括 兩 名 執 行 董 事，即 黃 少 華 博 士 及 黃 宓 芝 女 士；以 及 四 名 獨 立 非 執 行 董 事，即 劉 建 德 博 士、Anthony Graeme Michaels先 生、梁 慧 玲 女 士 及 史 維 教 授。 科勁國際（控 股）有限公司（「本公司」）董事會（「董事會」）宣 佈，董 事 會 會 議 將 於 二 零二五年八月二十二日（星 期 五）在本公司總部及香港主要營業地點香港 ...

Group 1 - KJ International (06822.HK) sold a total of 4,114,080 shares of China Construction Bank at an average price of approximately HKD 7.21 per share, totaling around HKD 29,663,000 excluding transaction costs [1] - High雅光学 (00907.HK) plans to establish different subsidiaries to engage in liquor, eyewear, and gold jewelry-related businesses [1] - Southern Manganese (01091.HK) aims to reduce group liabilities by HKD 300 million to HKD 500 million annually over the next five years [1] Group 2 - Stone Four Pharmaceutical Group (02005.HK) obtained the drug production registration certificate for calcium gluconate and sodium chloride injection (100ml) from the National Medical Products Administration [2] - Yanda Pharmaceutical (00512.HK) completed patient enrollment for the international multi-center Phase III clinical trial of the global innovative ophthalmic drug CBT-001 [2] - Zhaoke Ophthalmology-B (06622.HK) received FDA approval for the new drug trial application for cyclosporine eye gel [2] Group 3 - Anta Sports (02020.HK) granted a total of approximately 10.45 million reward shares [3] - Tencent Holdings (00700.HK) repurchased 980,000 shares at a cost of HKD 500 million on June 4 [3] - AIA Group (01299.HK) repurchased 3.25 million shares at a cost of HKD 215 million on June 4 [3]

Financial Performance - The group's total revenue for the fiscal year ending December 31, 2024, reached approximately HKD 833.9 million, a significant increase compared to HKD 691.1 million in 2023[10]. - The net profit attributable to shareholders for the year was approximately HKD 21.8 million, recovering from a loss of HKD 14.8 million in the previous year[10]. - For the fiscal year ending December 31, 2024, the company reported a revenue increase of approximately 20.7%, rising from about HKD 691.1 million to approximately HKD 833.9 million[28]. - The increase in revenue was attributed to a shift in consumer spending trends towards more personalized products, resulting in increased orders from American customers[28]. - Gross profit increased by approximately 15.1% to about HKD 206.9 million, while gross margin decreased by about 1.2 percentage points to approximately 24.8%[29]. - The company reported a total comprehensive income of HKD 17,083,000 for the year, compared to a loss of HKD 15,470,000 in 2023[179]. - The company reported a net profit of HKD 21,835,000 for the year ending December 31, 2024, compared to a loss of HKD 14,829,000 in the previous year[184]. Dividends and Shareholder Returns - The board proposed a final dividend of HKD 0.04 per share to reward shareholders for their support[10]. - The company proposed a final dividend of HKD 0.04 per share for the year ending December 31, 2024, compared to HKD 0.02 per share in 2023[110]. - The company paid dividends of HKD 14,000,000 to shareholders, down from HKD 21,000,000 in the previous year[188]. Assets and Liabilities - Non-current assets decreased to HKD 282.7 million from HKD 290.3 million in 2023, while current assets also saw a decline to HKD 497.6 million from HKD 514.0 million[6]. - Total assets as of December 31, 2024, were HKD 780,289,000, a decrease from HKD 804,312,000 in 2023[180]. - The company's equity totalled HKD 585,026,000 as of December 31, 2024, down from HKD 604,596,000 in 2023[182]. - The debt-to-equity ratio as of December 31, 2024, was approximately 22.5%, compared to 21.0% in the previous year[42]. - The debt-to-asset ratio increased from approximately 21.0% in 2023 to about 22.5% in 2024, an increase of 1.5 percentage points[98]. Market Strategy and Expansion - The group plans to launch several new products in 2025, focusing on drinkware and storage products, and aims to integrate IoT technology into lifestyle products[14]. - The group is expanding its market presence in the Asia-Pacific region and enhancing partnerships with existing customers[14]. - The group aims to further expand its business scale in the Chinese market through collaborations with local chain stores[14]. - The company has established a supply chain system outside of China to mitigate the impact of uncertainties in U.S. tariff policies[11]. Governance and Compliance - The board consists of two executive directors and four independent non-executive directors, ensuring a balance of power and authority[48]. - The company has adopted the corporate governance code and has complied with it, except for the provision that the roles of chairman and CEO should be separated[48]. - The board has established four committees: Audit Committee, Remuneration Committee, Nomination Committee, and Risk Management Committee to oversee various aspects of the company[50]. - All directors confirmed compliance with the standard code for securities trading throughout the year[49]. - The company has established a risk management and internal control system to ensure compliance and operational effectiveness[77]. Employee and Talent Management - The total employee cost for the year ending December 31, 2024, was approximately HKD 60.8 million, compared to HKD 57.8 million for the year ending December 31, 2023, reflecting an increase of about 5.2%[145]. - The group had approximately 152 employees as of December 31, 2024, a slight decrease from 154 employees as of December 31, 2023[145]. - The company provides competitive compensation and performance rewards to retain top talent, including salary, medical insurance, and long-term service awards[105]. Risk Management - The company continues to monitor risks such as foreign currency risk, credit risk, and market uncertainties that may impact profitability[93]. - The global market and operating environment remain unstable due to high inflation, tightening monetary policies, and geopolitical tensions[27]. - The company is adopting a cautious financial strategy to navigate potential market fluctuations and geopolitical tensions[11]. Environmental and Social Responsibility - The company has established an environmental policy aimed at reducing carbon emissions and promoting recycling initiatives[100]. - Charitable donations and other contributions totaled HKD 4,110,000 for the year, up from HKD 3,498,000 in 2023[121]. Audit and Financial Reporting - The financial statements for the year ending December 31, 2024, were audited by Hong Kong Li Xin De Hao CPA Limited[158]. - The audit report provides reasonable assurance that the financial statements are free from material misstatement due to fraud or error[173]. - The board is responsible for preparing the financial statements in accordance with the Hong Kong Financial Reporting Standards and ensuring the accuracy of the financial reporting process[171].